CAS: 205059-39-8 - tert-butyl 4-piperazin-1-ylpiperidine-1-carboxylate hydrochloride
Formula:C14H28ClN3O2
InChI:InChI=1/C14H27N3O2.ClH/c1-14(2,3)19-13(18)17-8-4-12(5-9-17)16-10-6-15-7-11-16;/h12,15H,4-11H2,1-3H3;1H
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | tert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate hydrochloride REF: 54-OR1022424CAS: 205059-39-8 | - - - | 193.00 €~713.00 € | Fri 17 Jan 25 |
 | 1-(1-Boc-piperidin-4-yl)-piperazine hydrochloride REF: 10-F033872CAS: 205059-39-8 | 98.0% | To inquire | Tue 21 Jan 25 |
 | 1-(1-BOC-PIPERIDIN-4-YL)-PIPERAZINE HCL REF: IN-DA00BENOCAS: 205059-39-8 | 98% | - - - | Discontinued product |
 | 1-(1-Boc-piperidin-4-yl)-piperazine hydrochloride REF: 3D-FIA05939CAS: 205059-39-8 | Min. 95% | - - - | Discontinued product |
tert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate hydrochloride
CAS:205059-39-8
Molecular weight:
305.84402g/mol
Ref: 54-OR1022424
| 1g | 193.00 € | ||
| 5g | 713.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
1-(1-Boc-piperidin-4-yl)-piperazine hydrochloride
CAS:205059-39-8
Purity:
98.0%
Color and Shape:
Solid
Molecular weight:
305.8500061035156
Ref: 10-F033872
| 2g | 177.00 € | ||
| 10g | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
1-(1-BOC-PIPERIDIN-4-YL)-PIPERAZINE HCL
CAS:205059-39-8
Formula:
C14H28ClN3O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
305.8440
Ref: IN-DA00BENO
| 1g | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
1-(1-Boc-piperidin-4-yl)-piperazine hydrochloride
CAS:205059-39-8
Versatile small molecule scaffold
Formula:
C14H28ClN3O2
Purity:
Min. 95%
Molecular weight:
305.84 g/mol
Ref: 3D-FIA05939
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 25g | Discontinued | Request information | |
| 50g | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
